2 March 2017
The guidelines outline administration, warnings, precise dosing, possible drug interactions and side effects.
In Italy medical cannabis is approved for patients suffering from severe conditions including chronic pain; spasms associated with pain, such as those suffering from spinal cord lesions or multiple sclerosis; patients undergoing chemotherapy, radiotherapy, and HIV therapies; drug-resistant glaucoma; and Tourette’s syndrome.
Additionally, medical cannabis use is permitted in cases that require appetite stimulation, such as cachexia and anorexia.
The guidelines allow for medical cannabis use when all other conventional treatments fail.
Here it is in pdf format (10pp)Ministero-della-Salute-RACCOMANDAZIONI-PER-IL-MEDICO-PRESCRITTORE-DI-SOSTANZA-VEGETALE-CANNABIS-FM2-INFIORESCENZE-2017